Fact-checked by Grok 2 weeks ago

Polysomy

Polysomy is a chromosomal condition characterized by the presence of extra copies of one or more chromosomes in a cell, resulting in a number that exceeds the normal diploid complement but is not a multiple of the haploid set. As a specific form of aneuploidy, polysomy typically arises from nondisjunction events during meiosis or mitosis, where chromosomes fail to separate properly, leading to gametes or daughter cells with supernumerary chromosomes. Common subtypes include trisomy (three copies of a chromosome, denoted as 2N+1) and tetrasomy (four copies, denoted as 2N+2), though higher-order polysomies such as pentasomy or hexasomy also occur. In humans, polysomy is associated with several congenital disorders due to gene dosage imbalances from the extra chromosomal material. For instance, Down syndrome results from trisomy 21, where individuals have three copies of chromosome 21, leading to intellectual disability, characteristic facial features, and increased risk of congenital heart defects. Similarly, Klinefelter syndrome involves an extra X chromosome in males (47,XXY karyotype), causing hypogonadism, infertility, and taller stature. Less common examples include tetrasomy 9p syndrome and various sex chromosome polysomies like 48,XXXY or 49,XXXXY, which present with developmental delays, physical anomalies, and endocrine issues. Beyond congenital conditions, polysomy is prevalent in , where it contributes to genomic instability and tumor progression in cancers such as (e.g., apparent polysomy 17) and leukemias (e.g., 12). In these cases, extra chromosome copies often amplify oncogenes or disrupt regulatory pathways, and detection via () helps assess prognosis and treatment response. Polysomy also manifests across diverse species, including fungi, , , and other mammals, where it can influence evolutionary or vigor in polyploid contexts. In autopolyploid , for example, polysomic inheritance—where multiple homologous chromosomes segregate randomly—allows for greater but complicates breeding and transmission. Overall, while often deleterious in diploids due to proteotoxic stress and developmental disruptions, polysomy's effects vary by , involved, and genetic background.

Definition and Classification

Definition

Polysomy is a chromosomal abnormality characterized by the presence of three or more copies of one or more specific in the cells of an , rather than the typical diploid complement of two copies per chromosome pair. This condition represents a type of , where the total chromosome number deviates from the normal euploid state, but unlike —which involves duplication of entire chromosome sets—polysomy affects only individual or chromosome arms. The term encompasses various degrees of multiplicity, such as (three copies, denoted as 2N+1), tetrasomy (four copies, 2N+2), and higher orders like pentasomy. For instance, , known as in humans, results from an extra copy of and leads to characteristic developmental and physical features. These extra chromosomes often arise from errors in , such as during or , leading to imbalances in that can disrupt normal cellular function and organismal development. In polyploid organisms, particularly in and fungi, polysomy can also describe inheritance patterns where multiple homologous chromosomes (more than two) pair and segregate randomly during , resulting in polysomic as opposed to disomic inheritance seen in diploids. This multivalent pairing complicates genetic transmission and can contribute to or instability in polyploid . Autopolyploids, derived from within-species genome duplication, frequently exhibit polysomic for many loci, while allopolyploids may show a mix of polysomic and disomic patterns depending on between subgenomes.

Terminology and Types

Polysomy refers to the genomic condition in which a or possesses more than the normal diploid number (two copies) of one or more specific , resulting in three or more copies of those . This abnormality is a subtype of , specifically hyperploidy, and contrasts with , which involves duplication of entire chromosome sets rather than individual . The term "polysomy" derives from the Greek "poly-" meaning many and "-somy" relating to , emphasizing the multiplicity of copies beyond the euploid state. In cytogenetic nomenclature, polysomy is often denoted by specifying the chromosome number and copy count, such as "" for three copies of 21. Types of polysomy are primarily classified based on the number of chromosome copies involved, ranging from the relatively common to rarer higher-order forms like pentasomy or hexasomy. , the most prevalent type, occurs when there are three copies of a , leading to conditions such as (trisomy 21), Edwards syndrome (trisomy 18), and (trisomy 13) in humans. Tetrasomy involves four copies and is less frequent, often arising from events; examples include tetrasomy 18p, which causes developmental delays, , and characteristic facial features due to an extra of the short arm of 18. Higher ploidy levels, such as pentasomy (five copies, e.g., 49,XXXXX in polysomy), are exceedingly rare and typically associated with severe congenital anomalies and reduced viability. Polysomy can also be categorized as full or partial depending on whether the entire or only a segment is duplicated. Full polysomy affects the whole , as in the examples above, while partial polysomy results from duplications or isochromosomes involving chromosome arms, such as partial 9p observed in certain syndromes. In non-human organisms, polysomy manifests similarly but may confer adaptive advantages in plants (e.g., extra copies enhancing for stress resistance) or occur mosaically in and fungi. Detection typically involves karyotyping, (FISH), or array comparative genomic hybridization (aCGH), with polysomy 7, 17, and 3 frequently identified in cancer as markers of genomic instability.

Etiology and Mechanisms

Genetic Causes

Polysomy arises primarily from errors in chromosome segregation during , leading to s or cells with extra copies of one or more s. The most common genetic mechanism is , where homologous chromosomes or fail to separate properly during or . In I, of homologous chromosomes results in s with two copies of a instead of one, and upon fertilization with a , this produces a trisomic exhibiting polysomy for that . Similarly, in II or can generate extra chromatids that become whole chromosomes, contributing to polysomy in cells or offspring. This process is frequently linked to defects in -microtubule attachments and centromeric . Weakened , particularly in aging oocytes due to progressive loss of cohesin proteins like Rec8 and SMC1β, increases the likelihood of premature separation of or merotelic attachments, where a binds microtubules from both spindle poles. Such errors are exacerbated in human females, where oocytes remain arrested in I for decades, leading to a maternal age effect; the incidence of , including polysomy, rises sharply after age 35, with maternal I errors accounting for over 90% of cases in trisomies like ( 21). In addition to , other genetic factors include mutations affecting assembly checkpoint (SAC) proteins, such as MAD2 or BUBR1, which fail to halt until proper attachments are ensured, allowing lagging to missegregate. Hyperstable kinetochore attachments or extra centrosomes can also promote multipolar , further driving gain in polysomic states. These are conserved across eukaryotes but vary in ; for instance, in , polysomy often stems from unreduced (2n) gametes formed via meiotic restitution, where alterations or failures omit segregation steps, leading to extra copies upon fertilization. Seminal studies highlight that such errors underlie at least 5-20% of conceptions and are key drivers of evolutionary variation in polyploid .

Environmental and Developmental Factors

Environmental and developmental factors play a significant role in the of polysomy by disrupting segregation during or , leading to and extra copies. These factors often interact with genetic predispositions, increasing the likelihood of aneuploid gametes or cells across various . In animals, is a primary developmental risk, as aging s accumulate recombination errors and assembly defects, elevating rates—particularly for prone to polysomy like 21 in humans, where the risk rises exponentially after age 35. Similarly, disruptions during fetal development, such as altered recombination patterns, can predispose cohorts of s to segregation errors in adulthood. In humans and other mammals, environmental exposures exacerbate these risks. Endocrine disruptors like (BPA) induce spindle aberrations and meiotic delays in oocytes, correlating with higher in exposed populations; for instance, BPA in follicular fluid is linked to reduced oocyte maturity and increased chromosomal abnormalities. and smokeless tobacco use, independent of age, heighten meiosis II nondisjunction for by reducing recombination frequency, with odds ratios up to 2.77 in affected families. and pesticide exposure, such as trichlorfon, further promote spindle disruptions and sperm or oocytes in model animals like mice and fish. In , developmental processes like produce unreduced (2n) , often resulting in polysomic progeny upon fertilization, especially in hybrids where univalent fail to pair properly. Environmental stresses, including extreme (e.g., above 36°C in roses or cold below 5°C in ), trigger spindle defects and failure, boosting 2n gamete formation by up to 50% and leading to aneuploid sectors. , an intercellular chromosome transfer during , is enhanced by high or moisture stress in species like and , generating polysomic and contributing to . For fungi, developmental cell cycle checkpoints are sensitive to environmental cues, where nutrient limitation or osmotic stress induces mitotic errors, yielding transient as an adaptive response; for example, in , such stresses promote chromosome missegregation to explore under adverse conditions. Overall, these factors underscore polysomy's role in both and , with quantitative impacts varying by organism—e.g., stress-induced rates can reach 10-20% in stressed meiocytes versus baseline levels below 1%.

Occurrence in Animals

In Mammals

In mammals, polysomy, characterized by the presence of extra chromosomes beyond the normal diploid set, is predominantly deleterious and frequently results in embryonic or fetal lethality due to imbalances disrupting development. Autosomal polysomies, such as , occur in a significant proportion of early embryos across , often arising from meiotic errors, but viable live births are exceedingly rare outside of humans. In human pregnancies, affects approximately 35-50% of embryos, with (Down syndrome) being the most common surviving form, occurring in about 1 in 640 live births and associated with , congenital heart defects, and other anomalies. 18 and 13 also reach live birth in roughly 1 in 3,336 and 1 in 6,967 cases, respectively, but typically lead to severe developmental issues and high postnatal mortality. In non-human mammals, autosomal are even less tolerated; for instance, in , they contribute to over 50% of pregnancy losses before day 55, with affecting chromosomes syntenic to human 3, 4, and 20, often alongside triploidy. Similarly, in , SNP array analysis of over 779,000 juveniles revealed autosomal in only 0.017% of cases, primarily maternal in origin and concentrated on smaller chromosomes like BTA 27, with affected individuals showing reduced viability—many dying within months and none surviving long-term on certain chromosomes. Sex chromosome polysomies are generally better tolerated in mammals due to dosage compensation mechanisms like , allowing survival into adulthood despite reproductive impairments. The , analogous to human , has been documented in various species, including domestic cats (Felis catus), dogs (Canis familiaris), and notably a (Panthera tigris altaica), where it manifests as , small testes, and , with scarce seminiferous tubules observed histologically. These cases often stem from during and highlight conserved phenotypic effects across mammals, such as reduced testosterone and altered secondary sexual characteristics. XXX and variants are rarer but reported in mice and , sometimes as mosaics, with milder impacts on viability but consistent fertility issues. A notable exception to the of polysomy in mammals is the presence of supernumerary B chromosomes, which are dispensable, non-homologous extra chromosomes occurring naturally in populations without disrupting essential functions. These have been identified in approximately 85 mammalian (about 1.94% of karyotyped ), predominantly in of the family , such as the yellow-necked mouse (Apodemus flavicollis) and Korean field mouse (Apodemus peninsulae), where individuals may carry 1-30 Bs with population frequencies ranging from 0 to 100%. B chromosomes vary in morphology (e.g., microchromosomes in possums like Petauroides volans or acrocentrics in foxes like Vulpes vulpes) and can influence traits including body size, behavior, and recombination rates, often through selfish drive mechanisms that bias transmission. Molecular analyses confirm they contain protein-coding genes in like the (Capreolus pygargus), challenging views of Bs as inert and suggesting adaptive roles in some contexts. Unlike pathological polysomies, Bs persist across generations and geographic ranges, as seen in European populations of A. flavicollis.

In Insects

Polysomy, a form of involving extra copies of specific chromosomes, has been extensively studied in , particularly in the Drosophila melanogaster. In this species, whole-chromosome aneuploidies such as trisomies lead to reduced organismal viability, primarily due to imbalances that disrupt and cellular function. Segmental trisomies, where portions of chromosomes are duplicated, show an inverse with fertility and viability, with larger duplicated segments causing more severe impairments. Mechanisms underlying polysomy in include nondisjunction and anaphase bridges during , which are exacerbated in parthenogenetic reproduction. In facultative parthenogenetic species like mercatorum, aneuploidy rates are higher in parthenogenetically produced offspring (up to 10.3% of cells) compared to sexually reproduced ones (3.6%), yet no overt tissue dysplasia is observed, suggesting tolerance mechanisms. buffering acts as a key compensatory response; for instance, genes in hemizygous (single-copy) regions from deficiencies are expressed at approximately 64% of wild-type levels rather than the expected 50%, mitigating dosage effects across much of the . The fourth exhibits particularly robust compensation mediated by the Painting of Fourth (POF) protein, allowing viability in haplo-4 flies that would otherwise be lethal. Pathophysiological effects of polysomy in manifest as cellular stress responses, including proteotoxic stress, production, and mitochondrial dysfunction, often triggering JNK-dependent or to eliminate aneuploid cells. When is suppressed, aneuploid cells can drive tumor-like overgrowth and invasiveness, with gains in autosomes promoting proliferation via the JNK and Wingless pathways. In parthenogenetic contexts, polysomy contributes to intra-individual genomic variability without apparent developmental abnormalities, potentially enhancing adaptability, though larger-scale aneuploidies (e.g., ~3% of the as single copies) are lethal. Cell further maintains tissue integrity by purging segmental aneuploid cells based on ribosomal protein imbalances. Beyond , aneuploid and polyploid cellular heterogeneity has been noted in cell cultures of dipteran insects, indicating that polysomy-like states may arise naturally during or under stress, though specific polysomy studies remain limited to model systems. Induced polysomies via agents like colcemid in D. melanogaster produce triploid at frequencies up to 18%, highlighting the role of mitotic errors in generating such conditions experimentally.

Occurrence in Plants and Fungi

In Plants

In plants, polysomy refers to the presence of extra copies of one or more chromosomes beyond the normal diploid complement, such as trisomy (2n+1) or tetrasomy (2n+2), representing a form of aneuploidy. Unlike animals, plants often tolerate polysomy better due to their flexible genome architecture and frequent polyploidy, which provides genetic buffering against imbalance. This tolerance allows polysomic plants to survive and propagate, though typically with reduced vigor and fertility. Polysomy in primarily arises through meiotic , where chromosomes fail to segregate properly, producing gametes with extra chromosomes that fertilize to form aneuploid zygotes. It can also result from crosses involving polyploids, such as triploids to diploids, generating viable trisomic progeny. Early seminal work by Albert F. Blakeslee in the 1920s identified 12 distinct trisomic types in (jimsonweed), each corresponding to an extra copy of one of its 12 chromosomes, demonstrating chromosome-specific morphological alterations like enlarged organs or distorted growth. These trisomics became a foundational model for studying dosage effects, as homozygous revealed direct phenotypic impacts from imbalance. In model and crop plants, polysomy induces diverse, chromosome-specific phenotypes often linked to changes. For instance, in Arabidopsis thaliana, of chromosome 1 results in smaller rosettes and reduced stem diameter, while of chromosome 5 promotes triple branching and alters axillary development; these effects are additive in double and persist epigenetically in euploid . Transcriptomic analyses show upregulated expression from the extra chromosome, with partial dosage compensation and secondary imbalances in other genes, underscoring polysomy's role in disrupting regulatory networks. In crops like (Triticum aestivum), persistent whole-chromosome , including polysomy, occurs in 20–100% of synthetic allohexaploid lines across generations, particularly involving B-genome chromosomes (e.g., extra 1B or 5B), leading to pollen sterility and reduced seed set but enabling adaptive variation. Polysomy has practical utility in and , serving as a tool for and alien transfer. In and , trisomics facilitate locating genes by analyzing segregation ratios, while chromosome substitution via polysomic intermediates introduces beneficial traits from wild relatives. Examples include trisomics in (Solanum lycopersicum) for fruit quality genes and in (Hordeum vulgare) for yield-related loci, highlighting polysomy's contributions to crop improvement despite its fitness costs. Overall, while deleterious, polysomy exemplifies ' genomic , influencing through occasional fixation in polyploid lineages.

In Fungi

Polysomy, characterized by the presence of more than two copies of a specific , represents a key form of in fungi and contributes to their genomic , particularly in response to environmental stresses such as drugs or nutrient limitations. Unlike balanced , which involves complete sets of extra chromosomes, polysomy often arises from errors in chromosome segregation during or parasexual cycles, leading to transient or stable extra copies of individual chromosomes. This phenomenon is prevalent across fungal species, from yeasts to filamentous pathogens, where it enables rapid without requiring extensive sequence mutations. Fungi tolerate polysomy relatively well compared to higher eukaryotes due to their frequent haploid life stages and lack of stringent meiotic checkpoints, allowing aneuploid cells to propagate and evolve. In the model yeast , polysomy occurs naturally in wild, clinical, and industrial isolates, with up to 36% of diploid strains exhibiting after extended culturing. For example, genetic disruptions in the RNA1 gene, involved in processing, specifically promote polysomy of chromosome XIII by interfering with mitotic fidelity, resulting in viable cells with three or more copies. of chromosome III has been linked to enhanced tolerance in industrial strains, while extra copies of chromosomes II, VII, or VIII confer resistance to copper stress, illustrating how polysomy amplifies for adaptive traits. These events often stem from during and are detected through whole-genome sequencing or array in laboratory-evolved populations. Among pathogenic fungi, frequently displays polysomy, especially in clinical isolates exposed to , with approximately 5% carrying supernumerary chromosomes and higher rates in drug-resistant populations. of smaller chromosomes (4 through 7) is most common, driven by selection, and increases expression of genes like ERG11 on , enabling survival at elevated concentrations. Similarly, of chromosome 7 upregulates NRG1, promoting gastrointestinal colonization and filamentation. In , disomy of chromosomes 1 or 4 arises under stress, providing to other antifungals via effects. Filamentous species like also acquire polysomies during azole exposure, with extra copies of chromosomes containing genes enhancing . In Ashbya gossypii, a pathogen, aneuploid nuclei with polysomic chromosomes coexist in hyphae, supporting filamentous growth. Overall, these examples highlight polysomy's role in fungal and adaptation, often at the cost of reduced fitness in non-stressful conditions due to proteotoxic imbalances from imbalanced .

Pathophysiological Effects

Phenotypic Consequences

Polysomy, characterized by the presence of extra copies of one or more chromosomes, disrupts the balanced gene dosage essential for normal development and function, leading to a range of phenotypic abnormalities across organisms. In humans, autosomal polysomies such as trisomies 13, 18, and 21 typically result in severe congenital malformations, growth retardation, and intellectual disabilities, with most cases causing embryonic lethality or spontaneous abortion early in gestation. For instance, trisomy 21 (Down syndrome) manifests in over 70 distinct phenotypes, including hypotonia, characteristic facial features, atrioventricular septal defects in about 40-50% of cases, and increased susceptibility to autoimmune disorders, as well as to leukemia and Alzheimer's disease, with affected individuals showing a 1.5-fold increase in trisomic gene expression that triggers genome-wide deregulation of pathways such as autophagy and innate immunity. Trisomy 18 (Edwards syndrome) survivors exhibit clenched fists, rocker-bottom feet, and profound developmental delays, with survival beyond the first year in only about 5-10% of cases due to respiratory and cardiac complications. Sex chromosome polysomies in humans often have subtler but still significant effects, primarily impacting reproductive, cognitive, and physical traits, as partial dosage compensation via mitigates some imbalances. (47,XXY) affects approximately 1 in 500-1,000 males and is associated with tall stature, , reduced testosterone levels leading to in nearly 100% of cases, and a higher incidence of learning disabilities and social challenges, with diagnosis frequently occurring post-puberty due to these endocrine disruptions. Triple X syndrome (47,XXX) in females, occurring in about 1 in 1,000 births, correlates with increased height, premature ovarian failure, and mild cognitive impairments such as delayed speech development, though many individuals remain undiagnosed due to less severe manifestations. Similarly, in males leads to taller stature and potential behavioral issues like impulsivity, but fertility is typically preserved and intellectual function is often normal, highlighting the variable expressivity influenced by genes. In non-human mammals, polysomy generally imposes greater fitness costs, often resulting in embryonic inviability or reduced viability, though viable models provide insights into human conditions. models of 21, generated via segmental duplication or Robertsonian translocations, recapitulate phenotypes including , impaired learning, and early-onset neurodegeneration linked to overexpression of genes like RCAN1 and . In canines, rare cases of prostate carcinoma with polysomy demonstrate aggressive tumor progression and , underscoring polysomy's role in oncogenesis similar to cancers. Across mammals, sex polysomies like in mice or cattle lead to sterility and , with disrupted due to imbalanced sex-determining , emphasizing the evolutionary intolerance for such imbalances in germ cells. Overall, phenotypic consequences of polysomy stem from proteotoxic and altered , where extra s cause stoichiometric imbalances in protein complexes, triggering cellular responses like mitochondrial dysfunction and heightened that exacerbate developmental and pathological outcomes. These effects underscore polysomy's pathophysiological burden, particularly in mammals where often hinges on the specific chromosome involved and compensatory mechanisms.

Role in Disease and Evolution

Polysomy, as a form of involving extra copies of chromosomes or chromosomal segments, plays a significant role in human genetic diseases by disrupting gene dosage balance and leading to developmental abnormalities. In , trisomy 21 results in , characteristic facial features, and increased risk of congenital heart defects and , affecting approximately 1 in 700 live births. Similarly, (47,XXY), a common polysomy in males, is associated with , , taller stature, and elevated risks of metabolic disorders, autoimmune conditions, and , with an incidence of about 1 in 500 to 1,000 newborn males. Higher-degree polysomies, such as 48,XXXY or 49,XXXXY variants, exacerbate these phenotypes, including more severe cognitive impairments and skeletal anomalies, though they are rarer. Y chromosome polysomy (e.g., 47,XYY) is linked to increased mortality from cardiovascular and respiratory diseases, as well as slightly higher cancer incidence, based on cohort studies of affected individuals. In , polysomy contributes to disease progression by fostering genomic instability and tumor heterogeneity, enabling cancer cells to evade therapies and metastasize. For instance, 17 polysomy in complicates HER2 testing and correlates with aggressive tumor behavior and poorer , often co-occurring with amplifications of oncogenes like ERBB2. Polysomy 8 in myeloid malignancies defines a subset with dismal outcomes, characterized by multilineage and rapid progression to . More broadly, , including polysomic states, drives "macroevolutionary" changes in tumors through chromosomal instability (CIN), promoting and , as evidenced in analyses of over 6,800 tumors across 32 cancer types where CIN-related mutations affected segregation fidelity. This instability creates a vicious cycle, where initial induces further chromosomal errors, amplifying expression and suppressing tumor suppressors. Beyond pathology, polysomy facilitates evolutionary in various organisms by generating rapid under stress, particularly in and unicellular eukaryotes where tolerance to imbalance is higher than in animals. In , disomic strains (extra chromosome copies) exhibit initial fitness costs but evolve compensatory s, restoring growth rates to near wild-type levels within hundreds of generations and increasing mutation rates up to eightfold on duplicated chromosomes, thus accelerating to limitation or shifts. In like , triploid intermediates produce aneuploid progeny with variable karyotypes, promoting , polyploid formation, and allelic biases that enhance and environmental resilience, as seen in recombinant lines where ploidy-dependent selection favors certain loci. Such mechanisms underscore polysomy's dual nature: deleterious in stable environments but potentially advantageous in dynamic ones, contributing to in polyploid-rich lineages like .

Diagnostic Methods

Cytogenetic Techniques

Cytogenetic techniques are essential for detecting polysomy, a form of characterized by the presence of extra copies beyond the normal diploid set, by visualizing and enumerating chromosomes in cell preparations. These methods, which range from classical microscopic analysis to fluorescence-based hybridization, enable the identification of numerical abnormalities in both constitutional and contexts, such as prenatal diagnostics and cancer . While karyotyping provides a genome-wide view, targeted approaches like (FISH) offer rapid, specific detection, often complementing each other for comprehensive assessment. Conventional karyotyping, also known as analysis, remains the gold standard for detecting polysomy through direct visualization of the entire complement. This technique involves culturing cells (e.g., from blood, , or ) to obtain spreads, followed by staining with to produce characteristic light and dark bands for identification and counting. It reliably identifies extra chromosomes indicative of polysomy, such as trisomy 21 in or multiple copies in polysomy studies, with analysis typically requiring examination of 20 cells, or up to 50 for mosaicism detection. However, its resolution is limited to abnormalities larger than 5-10 megabases, and it demands for arrest, making it unsuitable for non-dividing samples. Fluorescence in situ hybridization (FISH) is a widely adopted molecular cytogenetic method for precise polysomy detection, particularly in interphase nuclei where metaphases are unavailable. It employs fluorescently labeled DNA probes that hybridize to specific chromosomal regions, such as centromeres (e.g., CEP7 for chromosome 7), allowing enumeration of copy numbers under a fluorescence microscope—typically showing three or more signals per nucleus for trisomy or higher polysomy. In clinical applications, like prenatal diagnosis, FISH targets common aneuploidies (chromosomes 13, 18, 21, X, Y) with near-100% sensitivity and specificity in validated studies, enabling results within 24-48 hours from samples like chorionic villi. For somatic polysomy in cancers, such as cholangiocarcinoma, locus-specific or centromeric probes distinguish true chromosomal gains from gene amplification, correlating extra copies (e.g., >8% cells with chromosome 7 polysomy) with poor prognosis. Limitations include its targeted nature, requiring prior suspicion of the affected chromosome, and potential signal overlap in high-polysomy cases. Recent advancements as of 2025 incorporate AI-driven image analysis to automate signal counting and improve detection of low-level mosaicism in FISH, enhancing efficiency in high-throughput settings. Advanced variants like spectral karyotyping (SKY) or multicolor FISH (mFISH) extend cytogenetic analysis by painting each chromosome with unique fluorophore combinations, aiding in the detection of complex polysomies involving rearrangements. These techniques, applied to spreads, facilitate identification of multiple extra chromosomes in heterogeneous populations, such as in tumor cells exhibiting polysomy 12 in . Overall, integrating karyotyping with FISH enhances diagnostic accuracy for polysomy, balancing broad screening with targeted confirmation across diverse biological systems.

Molecular and Imaging Techniques

Molecular techniques for detecting polysomy involve quantifying DNA copy numbers at specific chromosomal loci or genome-wide, enabling precise identification of extra chromosome copies beyond the normal diploid or polyploid state. These methods are widely applied in prenatal diagnostics, cancer research, and evolutionary studies across eukaryotes, including mammals, plants, and fungi. Key approaches include polymerase chain reaction (PCR)-based assays, array-based hybridization, and sequencing technologies, each offering varying resolution and throughput. As of 2025, combined approaches like karyotyping with copy number variation sequencing (CNV-seq) have improved detection rates for submicroscopic variants in prenatal samples. Quantitative fluorescence PCR (QF-PCR) targets short tandem repeats on chromosomes prone to polysomy, such as 13, 18, 21, X, and Y, amplifying them with fluorescent primers to assess copy number via peak ratios in electropherograms. This technique achieves high sensitivity (95.65%) and specificity (99.97%) for common aneuploidies, making it cost-effective and automatable for rapid screening, though it is limited to predefined targets and cannot detect structural variants or mosaicism below 20-30%. Multiplex ligation-dependent probe amplification (MLPA) employs multiple probes that ligate only upon matching target sequences, followed by amplification to quantify copy numbers for up to 50 loci simultaneously. It is particularly useful for detecting polysomy in clinical samples like , providing results in 24-48 hours with high accuracy for dosage-sensitive genes, but requires validation for novel variants and misses balanced rearrangements. Array comparative genomic hybridization (aCGH) compares fluorescently labeled test and reference DNA hybridized to arrays, detecting copy number gains or losses at resolutions down to 50-100 kb. Widely adopted for genome-wide polysomy screening in prenatal and contexts, it shows high concordance (approximately 99%) with traditional for detection, though it cannot phase haplotypes or detect low-level mosaicism without single-nucleotide polymorphism (SNP) integration. SNP microarray analysis extends copy number detection by genotyping SNPs across the genome, distinguishing polysomy from uniparental disomy via allele imbalance patterns. It excels in identifying segmental aneuploidies and triploidy with high accuracy (up to 100% in validation studies) for targeted chromosomes in diverse samples, including plant polyploids, but demands reference data and computational tools for interpretation. Next-generation sequencing (NGS), including whole-genome and targeted panels, counts sequencing reads aligned to reference chromosomes to infer copy numbers, often via binomial or z-score models. This method detects polysomy with >99% sensitivity and specificity, even in cell-free DNA for noninvasive prenatal testing, and is adaptable to non-model organisms like insects and fungi through shallow whole-genome sequencing; however, it is costlier and sensitive to sequencing biases or low input DNA. Emerging applications as of 2025 include exome sequencing pipelines that simultaneously detect aneuploidy and single-nucleotide variants, streamlining diagnostics in constitutional cases. Imaging techniques complement molecular methods by visualizing chromosomal abnormalities directly in cells or tissues, facilitating spatial confirmation of polysomy. Advanced variants like multicolor (M-FISH) or spectral karyotyping () employ combinatorial probe sets to paint entire chromosomes in distinct colors, enabling whole-genome visualization of polysomy in spreads. These techniques, with resolutions down to 1-5 , are seminal for complex in cancer and across eukaryotes, achieving near-100% accuracy for gross imbalances but requiring cell culturing and high-quality spreads. Digital image analysis integrates with software algorithms to quantify signals or DNA content, enhancing detection of low-level polysomy (e.g., 10-20% mosaicism) in cytology samples. In combination with confocal or , it provides three-dimensional mapping, vital for studying polysomy dynamics in dividing cells of diverse organisms, though throughput remains lower than purely molecular assays.

References

  1. [1]
    Polysomy (Concept Id: C1514212) - NCBI
    The condition of having additional copies of a chromosome present in a cell.
  2. [2]
    Genetics Dictionary
    ### Definition of 'Polysomy'
  3. [3]
    Polysomy Definition and Examples - Biology Online Dictionary
    Mar 1, 2021 · Polysomy is a condition where there is more than one copy of the chromosome relative to the normal. Trisomy (2N+1) and tetrasomy (2N+2) are examples of ...
  4. [4]
    Polysomy - an overview | ScienceDirect Topics
    An abnormality in chromosome number is important because it is a common feature of genetic disorders and cancer. Aneuploidy is identified through ...
  5. [5]
    Down Syndrome - StatPearls - NCBI Bookshelf - NIH
    Aug 8, 2023 · Down syndrome (trisomy 21) is a genetic disorder caused by the presence of all or a portion of a third chromosome 21.
  6. [6]
    Klinefelter syndrome - Genetics - MedlinePlus
    Jul 10, 2023 · ... Klinefelter syndrome. Some people with features of Klinefelter syndrome have an extra X chromosome in only some of their cells, while the ...
  7. [7]
    clinical implications of polysomy 17 and genetic heterogeneity
    Apparent chromosome 17 polysomy, defined by increased chromosome enumeration probe 17 (CEP17) signal number, is a common genetic aberration in breast cancer ...Missing: definition | Show results with:definition
  8. [8]
    Genotypic Frequencies at Equilibrium for Polysomic Inheritance ...
    A peculiarity of polysomic inheritance is the possibility that a gamete inherits a single gene copy twice, termed double-reduction (Butruille and Boiteux 2000).
  9. [9]
    Genetics, Chromosome Abnormalities - StatPearls - NCBI Bookshelf
    Apr 24, 2023 · A chromosomal abnormality, or chromosomal aberration, is a disorder characterized by a morphological or numerical alteration in single or multiple chromosomes.Missing: polysomy | Show results with:polysomy
  10. [10]
    Polysomy – Knowledge and References - Taylor & Francis
    Polysomy refers to the state of a cell nucleus where some, but not all, of the chromosomes in a set are duplicated beyond the normal diploid number.<|control11|><|separator|>
  11. [11]
    Chapter 10: Ploidy: Polyploidy, Aneuploidy, and Haploidy
    75% of all angiosperms are polyploids, which are characterized by having more than two sets of chromosomes in their somatic cells.
  12. [12]
    Chromosomal Abnormalities - Understanding Genetics - NCBI - NIH
    The major chromosomal aneuploidies are trisomy 13, trisomy 18, Turner Syndrome (45, X), Klinefelter syndrome (47, XXY), 47XYY, and 47XXX. Structural chromosomal ...Missing: tetrasomy | Show results with:tetrasomy
  13. [13]
    Tetrasomy 18p - Genetics - MedlinePlus
    Apr 1, 2016 · Tetrasomy 18p is a chromosomal condition that affects many parts of the body. This condition usually causes feeding difficulties in infancy, ...
  14. [14]
    Tetrasomy Definition and Examples - Biology Online Dictionary
    Mar 1, 2021 · Tetrasomy is a type of aneuploidy where there is a gain of extra two chromosomes of the same type. The chromosomal composition is represented by 2N+2.
  15. [15]
    Nonrandom chromosomal abnormalities in malignant pleural ...
    The most frequent chromosomal abnormalities were polysomy or partial polysomy 7, monosomy or partial monosomy 22, and rearrangements involving breakpoints at ...
  16. [16]
  17. [17]
    Mechanisms of Aneuploidy - PMC - NIH
    Aneuploidy arising through chromosome mis-segregation during meiosis is a major cause of infertility and inherited birth defects.Mechanisms Of Chromosome... · Figure 1 · Consequences Of Aneuploidy
  18. [18]
  19. [19]
    Sexual polyploidization in plants – cytological mechanisms and ...
    Feb 20, 2013 · In the plant kingdom, events of whole genome duplication or polyploidization are generally believed to occur via alterations of the sexual ...
  20. [20]
    Human aneuploidy: mechanisms and new insights into an age-old ...
    The possibility that human aneuploidy may be induced by environmental factors such as smoking, drinking, oral contraceptive use and radiation exposure has been ...
  21. [21]
    Understanding etiology of chromosome 21 nondisjunction ... - NIH
    Maternal risk for DS child birth is multifactorial and includes factors of both genetic and environmental origin and challenges faithful chromosome segregation ...<|separator|>
  22. [22]
    Aneuploid sperm formation in rainbow trout exposed to the ... - NIH
    Dec 16, 2008 · Environmental contaminants that mimic native estrogens (i.e., environmental estrogens) are known to significantly impact a wide range of ...
  23. [23]
    Plant speciation through chromosome instability and ploidy change
    In this review, we describe the three major cytological mechanisms causing ploidy change: (1) meiotic non-reduction and 2n gamete formation, (2) somatic genome ...
  24. [24]
    Ploidy Variation in Fungi: Polyploidy, Aneuploidy, and Genome ...
    In this section, we will examine the different environments in which ploidy changes and acquisition of aneuploidy are documented in fungi and how these genome ...
  25. [25]
    Data and Statistics on Birth Defects - CDC
    Nov 19, 2024 · How many babies are affected each year? Trisomy 13. 1 in 6,967 births. 527. Trisomy 18. 1 in 3,336 births. 1,101. Trisomy 21 (Down syndrome). 1 ...
  26. [26]
    Naturally occurring horse model of miscarriage reveals ... - PNAS
    Over the embryonic period, coinciding to a period rarely accessible in women, equine miscarriage was associated with a high prevalence of triploidy (three ...Missing: mammals | Show results with:mammals
  27. [27]
    Prevalence of Autosomal Monosomy and Trisomy Estimated Using ...
    Oct 14, 2024 · The parental origin of the detected cases of trisomy was maternal for 92% of the cases. No cases of monosomy were detected despite the large ...3 Results · 3.1 Prevalence · 4 DiscussionMissing: mammals | Show results with:mammals<|control11|><|separator|>
  28. [28]
    (PDF) Klinefelter syndrome (39 XXY) in an adult Siberian tiger ...
    Aug 9, 2025 · The adult tiger exhibited signs of gonadal dysgenesis that is typically associated with this syndrome, including a scarce number of seminiferous ...
  29. [29]
    Animal models for Klinefelter's syndrome and their relevance for the ...
    When, due to meiotic non-disjunction events, males are born with a supernumerary X chromosome, the resulting 47, XXY karyotype is referred to as Klinefelter's ...
  30. [30]
    B Chromosomes in Populations of Mammals Revisited - PMC - NIH
    Oct 9, 2018 · B chromosomes are dispensable, supernumerary chromosomes, often smaller and morphologically different, that do not recombine with A chromosomes ...
  31. [31]
  32. [32]
  33. [33]
  34. [34]
    Aneuploid and polyploid cellular DNA heterogeneity in insect cell ...
    The occurrence of heterogenous cell populations with aneuploid and polyploid DNA content within the cell material of different developmental stages of diptera ...
  35. [35]
  36. [36]
    Effects of Aneuploidy on Genome Structure, Expression, and ... - NIH
    Oct 17, 2008 · Early work on plants and insects revealed that aneuploidy has a greater effect on phenotype than polyploidy [1],[2].Missing: polysomy | Show results with:polysomy
  37. [37]
    Phenotypic Consequences of Aneuploidy in Arabidopsis thaliana
    For example, plants trisomic for chromosome 1 (Tr.1) were much more severely affected than Chr.1, Chr.3 double trisomics (data not shown). Finally, one ...
  38. [38]
    The Globe, a Simple Trisomic Mutant in Datura - PNAS
    The Globe mutant differs from normals apparently in all parts of the plant. It shows a complex of characters readily recognized, whether the plants in question ...
  39. [39]
    Aneuploidy in plants and flies: The origin of studies of genomic ...
    Aneuploidy, studied in plants and flies, is generally detrimental, more severe than whole genome changes, and causes greater changes in gene expression.Missing: polysomy | Show results with:polysomy
  40. [40]
  41. [41]
    Trisomics - an overview | ScienceDirect Topics
    Blakeslee and his co-workers in 1920, phenomenon of trisomy has been reported in a number of plant species (Oryza sativa, Triticum, Zea mays, Hordeum vulgare, ...
  42. [42]
    Chromosome Specificity of Polysomy Promotion by Disruptions of ...
    Abstract. Previously, we showed that a disruption of the yeast RNA1 gene with LEU2 sequences promotes polysomy for chromosome XIII.
  43. [43]
  44. [44]
    Aneuploidy confers a unique transcriptional and phenotypic profile ...
    Apr 6, 2025 · Our work demonstrates common transcriptional and phenotypic features of aneuploid C. albicans cells with consequences for infection of different host niches.Missing: polysomy | Show results with:polysomy
  45. [45]
    Genomic Plasticity of the Human Fungal Pathogen Candida albicans
    Jul 1, 2010 · Trisomy was much more frequently observed than monosomy, and trisomy of the smaller chromosomes, Chrs4 to -7, was detected most frequently.
  46. [46]
    Aneuploidy is a Prevalent Strategy in Fungal Adaptation - PMC - NIH
    Oct 10, 2019 · Aneuploidy in wild yeast strains is often associated with morphological changes, including elongated pseudohyphal growth and filamentous ...
  47. [47]
    Aneuploidy Formation in the Filamentous Fungus Aspergillus flavus ...
    Jun 26, 2023 · Aneuploidy confers azole resistance in A. flavus strains. Exposure to high concentrations of VRC results in an increase in gene copy number across multiple ...Missing: examples | Show results with:examples
  48. [48]
    Consequences of chromosome gain: A new view on trisomy ... - NIH
    Chromosome gains are detrimental for the development of the human embryo. As such, autosomal trisomies almost always result in spontaneous abortion.Missing: polysomy animals
  49. [49]
    PHENOTYPE MANIFESTATIONS OF POLYSOMY X AT MALES - PMC
    Klinefelter Syndrome is the most frequent form of male hypogonadism. It is an endocrine disorder based on sex chromosome aneuploidy.
  50. [50]
    Sex chromosome aneuploidies - ScienceDirect.com
    We discuss five of the better-known sex aneuploidies: Turner syndrome (XO), Klinefelter syndrome (XXY), trisomy X (XXX), XYY, and XXYY. Despite their prevalence ...
  51. [51]
    Polysomy 13 in a canine prostate carcinoma underlining its ...
    The dog could serve as a genetic model, for example in cancer predisposition, development, and progression. For instance, beside man the dog is the only known ...
  52. [52]
    Polyploidy in Animals: Effects of Gene Expression on Sex ...
    Jun 28, 2013 · We review a selection of old and recent literature on polyploidy in animals, with emphasis on the consequences of polyploidization for gene expression patterns.
  53. [53]
    Down syndrome - PubMed - NIH
    Feb 6, 2020 · Trisomy 21, the presence of a supernumerary chromosome 21, results in a collection of clinical features commonly known as Down syndrome (DS).
  54. [54]
    Klinefelter Syndrome and Other Sex Chromosomal Aneuploidies
    Oct 24, 2006 · The term Klinefelter syndrome (KS) describes a group of chromosomal disorder in which there is at least one extra X chromosome to a normal ...Missing: polysomy | Show results with:polysomy
  55. [55]
    X-chromosome polysomy in the male. The Leuven experience 1966 ...
    A review of 569 male patients with X-chromosome polysomies (544 Klinefelter and 25 patients with other types of X-chromosome polysomy) is presented here.
  56. [56]
    Mortality and cancer incidence in males with Y polysomy in Britain
    Apr 25, 2007 · This study provides evidence that mortality rates from several specific causes are raised among men with Y polysomy.
  57. [57]
    Polysomy 17 in breast cancer: clinicopathologic significance and ...
    Oct 20, 2008 · Polysomy 17 affects HER-2 testing in breast cancer and is a major cause of equivocal results by FISH.
  58. [58]
    Polysomy 8 defines a clinico-cytogenetic entity representing a ...
    Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort ...
  59. [59]
    The Role of Aneuploidy in Cancer Evolution - PubMed
    Jan 3, 2017 · Aneuploidy, a chromosomal aberration, contributes to tumor heterogeneity, drug resistance, treatment failure, and may allow "macroevolutionary" ...
  60. [60]
    Aneuploidy and chromosomal instability: a vicious cycle driving ...
    Aneuploidy, a result of chromosomal instability, can cause gene dosage changes, leading to chromosomal instability, creating a "vicious cycle".
  61. [61]
    Molecular signatures of aneuploidy-driven adaptive evolution
    Jan 30, 2020 · Rapid aneuploidy-driven adaptation was observed for diverse genetic and environmental perturbations (e.g., telomerase deficiency, heat shock, ...
  62. [62]
    Aneuploidy and Genetic Variation in the Arabidopsis thaliana ... - NIH
    Recurring selection of plants for aneuploidy tolerance may play an important evolutionary role and have consequences on their response to dosage regulation.
  63. [63]
    Persistent whole-chromosome aneuploidy is generally associated ...
    Aneuploidy of chromosomes 4B and 6B were associated with 14% and 10% of the plants. Among the A genome chromosomes, 6A was most frequently associated aneuploidy ...Results · Chromosome Loss Or Gain... · DiscussionMissing: polysomy | Show results with:polysomy
  64. [64]
    Genetics, Cytogenetic Testing and Conventional Karyotype - NCBI
    Aug 8, 2023 · Cytogenetic testing is the examination of chromosomes to determine chromosome abnormalities such as aneuploidy and structural abnormalities.Missing: polysomy | Show results with:polysomy
  65. [65]
    Molecular cytogenetic and rapid aneuploidy detection methods in ...
    Feb 8, 2007 · Quantitative fluorescence (QF) PCR and several other new methods under investigation, collectively referred to as rapid aneuploidy detection or ...
  66. [66]
  67. [67]
    Karyotyping for Chromosomal Abnormalities - Nature
    Karyotyping is the process of pairing and ordering all the chromosomes of an organism, thus providing a genome-wide snapshot of an individual's chromosomes.Missing: polysomy | Show results with:polysomy
  68. [68]
    Fluorescence in situ hybridization detection of chromosome 7 and/or ...
    May 19, 2022 · Fluorescence in situ hybridization (FISH) is one of the cytogenetic approaches that has been used to investigate chromosomal aberration in both ...
  69. [69]
    Recent Molecular Techniques in Cytogenetics - IntechOpen
    Techniques like fluorescence in situ hybridization (FISH) are commonly used to detect chromosomal abnormalities associated with genetic diseases and cancer [6].2.1 Spectral Karyotyping... · 4. Applications In... · 4.1 The Detection And...Missing: polysomy | Show results with:polysomy<|control11|><|separator|>
  70. [70]
  71. [71]
    Prenatal Screening Methods for Aneuploidies - PMC - NIH
    Rapid aneuploidy detection. Newer molecular cytogenetic techniques have been introduced which provide rapid results. They allow a rapid diagnosis of the ...Missing: polysomy | Show results with:polysomy<|control11|><|separator|>
  72. [72]
  73. [73]
    Fluorescence in situ hybridization for molecular cytogenetic analysis ...
    In this chapter, we describe protocols to perform three basic FISH techniques in filamentous fungi: (a) FISH mapping of unique sequences on the somatic ...Missing: polysomy plants<|control11|><|separator|>